Mai Capital Management Moderna, Inc. Transaction History

Mai Capital Management

$10.1 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$101.21 - $166.61 $38,459 - $63,311	380 Added 8.96%	4,622 $548,000
Q1 2024 May 08, 2024	SELL	$85.37 - $115.44 $43,794 - $59,220	-513 Reduced 10.79%	4,242 $452,000
Q4 2023 Feb 09, 2024	BUY	$69.51 - $104.43 $86,470 - $129,910	1,244 Added 35.43%	4,755 $472,000
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $99,687 - $130,914	-1,034 Reduced 22.75%	3,511 $362,000
Q2 2023 Aug 02, 2023	SELL	$118.5 - $160.53 $53,680 - $72,720	-453 Reduced 9.06%	4,545 $552,000
Q1 2023 May 10, 2023	SELL	$135.66 - $197.02 $111,376 - $161,753	-821 Reduced 14.11%	4,998 $767,000
Q4 2022 Feb 09, 2023	BUY	$118.38 - $210.04 $242,797 - $430,792	2,051 Added 54.43%	5,819 $1.05 Million
Q3 2022 Nov 15, 2022	SELL	$118.07 - $194.18 $17,828 - $29,321	-151 Reduced 3.85%	3,768 $446,000
Q2 2022 Jul 19, 2022	BUY	$117.13 - $176.59 $125,094 - $188,598	1,068 Added 37.46%	3,919 $560,000
Q1 2022 May 10, 2022	BUY	$126.46 - $235.05 $67,656 - $125,751	535 Added 23.1%	2,851 $491,000
Q4 2021 Feb 11, 2022	SELL	$225.82 - $368.51 $52,616 - $85,862	-233 Reduced 9.14%	2,316 $588,000
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $16,864 - $36,819	76 Added 3.07%	2,549 $981,000
Q2 2021 Jul 19, 2021	BUY	$129.91 - $234.98 $45,598 - $82,477	351 Added 16.54%	2,473 $581,000
Q1 2021 May 10, 2021	BUY	$109.18 - $185.98 $231,679 - $394,649	2,122 New	2,122 $278,000
Q4 2020 Feb 16, 2021	SELL	$65.74 - $169.86 $1.15 Million - $2.96 Million	-17,431 Closed	0 $0
Q3 2020 Oct 26, 2020	BUY	$54.34 - $94.85 $186,440 - $325,430	3,431 Added 24.51%	17,431 $1.23 Million
Q2 2020 Jul 27, 2020	BUY	$29.67 - $80.0 $415,380 - $1.12 Million	14,000 New	14,000 $899,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Mai Capital Management with notifications on news.

Account